Sleep problems in SpA & PsA? Study of 201 pts shows 43% of axSpA and 47% of PsA pts reported sleep problems. In both poor sleep assoc w/ dz activity. In axSpa it signif assoc w/ Dz activity (OR 8.45),biologic use (OR .24), & CRP levels (OR .16) https://t.co/9TEUOODO1P https://t.co/5IhVmOpTCB

Anifrolumab was studied in 7 adolescents w/ resistant #DLE (discoid); given 6 monthly IV doses. All had signif decreases in skin CLASI-A scores (72%) at 1 month (P =.01), sustained at 6-mo F/U. SLEDAI-2K score also decr by 7 pts; 1 had HSV-1 reactivation https://t.co/Nc0IN1Rsao https://t.co/XeAB99YZMF

Bimekizumab (Bimelex), a dual IL-17A/F inhibitor, is FDA approved for u Treatment of Adults with Moderate to Severe Plaque Psoriasis https://t.co/IeobNWcM94 https://t.co/OMbhVwFCCt

#PMR: Ageism, Pain and Drug Management Dr. Divyani Misra, Boston, discusses ageism, pain and drug management in older adults with polymyalgia rheumatica. https://t.co/opWAJoF8b3 https://t.co/0JUrdnGa8s

Learn about enhancing patient care in axSpA through this engaging video series, as Dr Lianne Gensler and Dr Atul Deodhar walk through the updates to the ASAS-EULAR Guidelines. https://t.co/NxGuOXPKjZ https://t.co/HdCGE3ZgpI

Fever of Unknown Origin Featuring Dr. Sebastian Sattui (Pittsburgh) 68 yr. old with fatigue and daily fevers of 101F; what's the differential diagnosis? https://t.co/il6EBLOp0M #PMR https://t.co/PL5DSdRb1s

Frailty in #PMR: Why do I need to care? https://t.co/JYbavonDWL https://t.co/aP97c6zFIH

Sleep Apnea Smart Watches Dr. Jack Cush reviews the news, journal reports and regulatory approvals from this past week on RheumNow. https://t.co/BbBa4JaOV3 https://t.co/vcOxbP6yhQ

#PMR with Cancer Dr. Sebastian Sattui (Pittsburgh, PA) Can PMR be a paraneoplastic presentation? https://t.co/fr2y9VLSMD https://t.co/RsANcK5pbi

TONIGHT at 7pm ET! Join us for #PMR & Steroid-Sparing Therapeutics featuring panelists Drs. Robert Spiera and Sarah Mackie, and moderator Dr. Sebastian Sattui . https://t.co/EslrRh7ArO https://t.co/3WY881eDGP

IL-6 Inhibitors in #PMR: Give early or late? https://t.co/Hg7ZJJxaGD https://t.co/cJdnTPI3YD

AbbVie US Medical Affairs sponsored posters are now available: Long-term Safety of a JAKi in Patients with RA With up to 6.5 Years of Exposure. https://t.co/0PQT6qExcQ https://t.co/PYbdwQeKEA